For CVD, elevated levels of VCAM-1 have been reported to be associated with future cardiovascular mortality in CAD patients (15), and for patients with STEMI, VCAM-1 predicts post-STEMI heart failure and is associated with the development of new post-acute myocardial infarction heart failure symptoms (16). Here, VCAM1 is linked to acute myocardial infarction.